PNC Financial Services Group
RVMD icon

PNC Financial Services Group’s Revolution Medicines RVMD Stock Holding History

PNC Financial Services Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Buy
8,441
+1,666
+25% +$243K ﹤0.01% 1167
2026
Q1 		$659K Sell
6,775
-3,291
-33% -$332K ﹤0.01% 1511
2025
Q4 		$802K Buy
10,066
+125
+1% +$8.2K ﹤0.01% 1381
2025
Q3 		$464K Buy
9,941
+2,246
+29% +$87.9K ﹤0.01% 1696
2025
Q2 		$283K Buy
7,695
+3,171
+70% +$122K ﹤0.01% 1967
2025
Q1 		$160K Buy
4,524
+3,518
+350% +$143K ﹤0.01% 2345
2024
Q4 		$44K Buy
1,006
+166
+20% +$8.38K ﹤0.01% 3167
2024
Q3 		$38.1K Buy
840
+237
+39% +$10.3K ﹤0.01% 3214
2024
Q2 		$23.4K Buy
603
+362
+150% +$13.5K ﹤0.01% 3398
2024
Q1 		$7.77K Buy
241
+185
+330% +$5.48K ﹤0.01% 3831
2023
Q4 		$1.61K Buy
+56
New +$1.35K ﹤0.01% 4228
2022
Q2 		– Sell
-829
Closed -$21K – 4681
2022
Q1 		$21K Buy
+829
New +$18K ﹤0.01% 3552
2020
Q3 		– Sell
-8
Closed – – 4029
2020
Q2 		$0 Buy
+8
New +$252 ﹤0.01% 4034

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

PNC Financial Services Group's RVMD Position: Q2 2026 in Review

PNC Financial Services Group increased its Revolution Medicines (RVMD) stake by 25% in Q2 2026, buying an estimated $243K and bringing the position to 8,441 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1167.

PNC Financial Services Group first reported a position in RVMD in Q2 2020 and has held it in 13 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • PNC Financial Services Group held 8,441 shares of Revolution Medicines worth $1.58M as of Q2 2026.
  • PNC Financial Services Group bought 1,666 Revolution Medicines shares in Q2 2026, an estimated $243K.
  • Revolution Medicines made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1167 holding.
  • PNC Financial Services Group first reported a position in Revolution Medicines in Q2 2020 and has held it in 13 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.